Related Experiment Videos
Liver transplantation for hepatic and biliary malignancy
1Department of Surgery, University of Western Ontario, and Multi-Organ Transplant Program, London Health Sciences Centre, London, Ontario, Canada.
Seminars in Liver Disease
|February 24, 2001
Summary
Liver transplantation offers a high cure rate for early-stage liver cancer, with careful patient selection being key. Survival rates approach 75% for selected hepatocellular carcinoma patients post-transplant.
Area of Science:
- Hepatobiliary Surgery
- Transplant Oncology
- Gastroenterology
Background:
- Liver transplantation has become a curative option for specific liver cancer stages.
- Patient selection criteria are crucial for successful outcomes.
Purpose of the Study:
- To review the evolving role and outcomes of liver transplantation in managing various primary and secondary liver malignancies.
- To highlight the importance of accurate preoperative assessment and the impact of different tumor types on transplant success.
Main Methods:
- Review of current literature and clinical practices regarding liver transplantation for liver cancer.
- Analysis of survival rates and recurrence patterns based on tumor type and stage.
- Discussion of imaging modalities and neoadjuvant therapies.
Main Results:
- Selected cirrhotic patients with early hepatocellular carcinoma achieve ~75% 5-year survival post-transplant.
- Fibrolamellar hepatoma and pediatric hepatoblastoma show favorable outcomes with transplantation.
- Cholangiocarcinoma and metastatic neuroendocrine tumors have poor prognoses despite transplantation.
Conclusions:
- Liver transplantation is highly effective for select early-stage liver cancers, particularly hepatocellular carcinoma.
- Outcomes vary significantly by tumor type, with cholangiocarcinoma and metastatic disease faring poorly.
- Continued research into neoadjuvant therapies and stringent selection criteria are vital for optimizing transplant outcomes in liver cancer patients.